Found: 3 articles
Article | Edition |
---|---|
Koshkin A.M., Pokrovskaya A.V.
Two-drug antiretroviral therapy regimen with dolutegravir and lamivudine for previously untreated HIV-infected patients
|
№3 / 2023 |
Kanestri V.G., Kravchenko A.V., Pokrovskaya A.V., Kulabukhova E.I., Kuimova U.A., Goliusova M.D., Kozyrina N.V., Shakhgildyan V.I., Yurin O.G.
Randomized, open-label, controlled, comparative study on switching HIV-infected patients with their antiretroviral therapy experience to a DTG and 3TC regimen: 96-weeks results
|
№4 / 2021 |
Kravchenko A.V., Kanestri V.G.
HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
|
№6 / 2015 |